MRP3 as a novel resistance factor for sorafenib in hepatocellular carcinoma

Oncotarget
Tetsu TomonariTetsuji Takayama

Abstract

The mechanism of resistance of hepatocellular carcinoma (HCC) to sorafenib is unknown and no useful predictive biomarker for sorafenib treatment has been reported. Accordingly, we established sorafenib-resistant HCC cells and investigated the underlying mechanism of resistance to sorafenib. Sorafenib-resistant cell lines were established from the HCC cell line PLC/PRF5 by cultivation under continuous exposure to increasing concentration of sorafenib. The IC50 values of the 2 resistant clones PLC/PRF5-R1 and PLC-PRF5-R2 were 9.2±0.47 μM (1.8-fold) and 25±5.1 μM (4.6-fold) respectively, which were significantly higher than that of parental PLC/PRF5 cells (5.4±0.17 μM) (p < 0.01 respectively), as determined by MTT assay. Western blot analysis of signal transduction-related proteins showed no significant differences in expression of AKT/pAKT, mTOR/pmTOR, or ERK/pERK between the 2 resistant clones versus parent cells, suggesting no activation of an alternative signal transduction pathway. Likewise, when expression of membrane transporter proteins was determined, there were no significant differences in expression levels of BSEP, MDR1, MRP2, BCRP, MRP4 and OCT1 between resistant clones and parent cells. However, the expression levels...Continue Reading

References

Dec 1, 1991·Journal of Neurosurgery·M W NaborsO M Colvin
Jan 18, 1989·Journal of the National Cancer Institute·L J GoldsteinG M Brodeur
Apr 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W S DaltonS E Salmon
Aug 2, 1989·Journal of the National Cancer Institute·S L LaiA F Gazdar
Mar 30, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J KönigD Keppler
Jun 9, 1999·Proceedings of the National Academy of Sciences of the United States of America·M KoolP Borst
Dec 18, 2001·International Journal of Cancer. Journal International Du Cancer·A T NiesD Keppler
Mar 29, 2002·International Journal of Cancer. Journal International Du Cancer·Yasuhiro TadaSeiji Naito
Jan 24, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Josep M Llovet, Jordi Bruix
Dec 4, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael C HeinrichJonathan A Fletcher
Feb 25, 2005·The New England Journal of Medicine·Susumu KobayashiBalázs Halmos
Aug 16, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ghassan K Abou-AlfaLeonard B Saltz
Jan 12, 2007·The New England Journal of Medicine·Bernard EscudierUNKNOWN TARGET Study Group
May 19, 2007·World Journal of Gastroenterology : WJG·Andreas TeufelPeter-R Galle
Jul 25, 2008·The New England Journal of Medicine·Josep M LlovetUNKNOWN SHARP Investigators Study Group
Feb 21, 2009·Drugs·Gillian M Keating, Armando Santoro
Sep 3, 2010·BMC Cancer·Chien-Tsun KuanDarell D Bigner
Sep 28, 2010·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Lie LiSharyn D Baker
Jan 6, 2011·The Journal of Pharmacology and Experimental Therapeutics·Kuen-Feng ChenAnn-Lii Cheng
Sep 20, 2011·European Journal of Pharmacology·Luigi FiumeGiuseppina Di Stefano
Aug 29, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Eric I ZimmermanSharyn D Baker
Apr 10, 2013·Journal of Cancer Research and Clinical Oncology·Nicola PersoneniArmando Santoro
Aug 6, 2014·Nature Reviews. Clinical Oncology·Alejandro FornerJean-Luc Raoul
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal

❮ Previous
Next ❯

Citations

May 4, 2017·Journal of Pharmaceutical Sciences·Nilay ThakkarKim L R Brouwer
Feb 22, 2018·Pathology Oncology Research : POR·Cinthya Santos CirqueiraVenâncio Avancini Ferreira Alves
Apr 1, 2017·Pharmacogenetics and Genomics·Li GongTeri E Klein
Jun 27, 2020·Cancers·Jose J G MarinOscar Briz
Jul 28, 2019·Clinical Pharmacology and Therapeutics·Mingqing ChenAnne T Nies
Jun 11, 2020·Therapeutic Advances in Medical Oncology·Guanghan FanXiao Xu
May 6, 2020·International Journal of Molecular Sciences·Maria KrchniakovaRenata Veselska
Oct 15, 2019·Frontiers in Nutrition·Marius FarcasIoana Berindan-Neagoe
Oct 7, 2020·Cancers·Christo KoleDimitrios Schizas
Nov 22, 2020·European Journal of Pharmacology·María Paula CeballosMaría Cristina Carrillo
Apr 14, 2021·Current Drug Targets·Maria Manuela EstevinhoJoão Carvalho

❮ Previous
Next ❯

Methods Mentioned

BETA
surgical resection
transfection
PCR
electrophoresis

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Auditory Perception

Auditory perception is the ability to receive and interpret information attained by the ears. Here is the latest research on factors and underlying mechanisms that influence auditory perception.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Related Papers

Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban
Gaopeng LiLu Ye
Drug Metabolism and Disposition : the Biological Fate of Chemicals
Tadashi NamisakiAnne T Nies
© 2022 Meta ULC. All rights reserved